This large cohort confirmed earlier data that 65–70% of BL have a detectable MYC-IGH fusion by the LD-PCR and that 30% of patients with available BM were MDD-positive, whereas only half of them were positive by cytology. The gene discussed is MYC; the disease is Burkitt lymphoma.